Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides (Q40967561)

25 September 2017

title

Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides (English)

1 reference

25 September 2017

1 reference

Watson K

1

1 reference

25 September 2017

Gooderham NJ

series ordinal

2

1 reference

25 September 2017

Davies DS

series ordinal

3

1 reference

25 September 2017

Edwards RJ

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

25 September 2017

published in

Biochemical Pharmacology

1 reference

25 September 2017

volume

57

1 reference

25 September 2017

issue

7

1 reference

25 September 2017

page(s)

775-783

1 reference

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Anti-HIV synergism between dextran sulphate and zidovudine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Angiogenic properties of human immunodeficiency virus type 1 Tat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

A quantitative bioassay for HIV-1 based on trans-activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Immobilization of proteins on oxidized crosslinked Sepharose preparations by reductive amination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

22 Antipeptide antibodies in studies of cytochromes P450IA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

A versatile synthetic peptide-based ELISA for identifying antibody epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

The trans-activator gene of HTLV-III is essential for virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Tat protein from human immunodeficiency virus forms a metal-linked dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Structural studies of HIV-1 Tat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Cellular uptake of the tat protein from human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

Antiviral activity of polyacrylic and polymethacrylic acids. II. Mode of action in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900352-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(98)00352-9

1 reference

25 September 2017

1 reference